-
In this randomized, double-blind, placebo-controlled study, Hickson and colleagues hypothesized that they could reduce the occurrence of antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) among older hospitalized patients taking antibiotics by feeding them a commercially-available probiotic yogurt drink.
-
Meersseman and colleagues at Gasthuisberg University Hospital in Leuven, Belgium, have extensive experience in studies of invasive aspergillosis (IA) in critically ill patients, including those without the traditional risk factors.
-
The death of a 12-day-old infant in New York City in May of 2006 was found to have been due to adenovirus serotype 14.
-
Beginning in 2000, the University of Pittsburgh Medical Center (UPMC) Presbyterian experienced a marked increase in hospital-acquired C. difficile infection, from 2.7 infections per 1000 discharges (0.46 per 1000 patient days) in the 2 preceding years to 7.2 per 1000 discharges (1.17 per 1000 patients days).
-
These three studies published back to back in JID serve to better characterize HPV infection in heterosexual men.
-
A military serviceman stationed in Hawaii, presented to base with intense pruritus, restlessness, dyspnea, and progressive paresthesias, with burning skin discomfort.
-
In June, 2006, the FDA licensed the first human papillomavirus vaccine (HPV) to prevent cervical cancer and other HPV-associated cancers: vaginal, urethral, and oral tumors. Is this yet another travel vaccine for our patients?
-
A retrospective cohort study of culture-negative (CN) prosthetic joint infection (PJI) was performed on patients who underwent total hip or total knee arthroplasty at Mayo Clinic from 1990-1999.
-
Micafungin at doses of both 100 mg and 150 mg daily was non-inferior to caspofungin in the treatment of invasive candidiasis and there was no significant difference in outcomes when the two doses of micafungin were compared.
-
Although imported cholera cases in developed countries, such as France, may continue to decline, the global number of cholera cases continues to rise at an alarming rate. Orally administered cholera vaccine may hold promise in controlling cholera epidemics.